The Effectiveness of Cancer Pain Management in a Tertiary Hospital Outpatient Pain Clinic in Thailand: A Prospective Observational Study
Table 2
Demographic data difference between pain responders and nonresponders at FU3.
Pain responders, n = 44
Nonresponders, n = 28
value
Age (years), median (IQR)
56.5 (47.0–65.5)
58.0 (49.0–65.5)
0.871
Gender, n (%)
0.225
Male
30 (68.2)
15 (53.6)
Female
14 (31.8)
13 (46.4)
BMI, median (IQR)
21.5 (17.9–24.2)
21.5 (17.6–23.6)
0.917
Status, n (%)
0.034
Married
35 (79.5)
15 (53.6)
Single/divorced/widowed
9 (20.5)
13 (46.4)
Living with, n (%)
1.000
Family/sibling
42 (95.5)
27 (96.4)
Alone
2 (4.5)
1 (3.6)
Education, n (%)
0.312
High school and below
31 (70.5)
16 (57.1)
Higher than high school
13 (29.5)
12 (42.9)
Pain score (NRS), median (IQR)
5.0 (4.0–7.0)
5.0 (4.0–6.0)
0.617
KPS (%), median (IQR)
70.0 (60.0–80.0)
75.0 (60.0–80.0)
0.807
Cancer status, n (%)
0.066
Local
11 (25.0)
2 (7.1)
Advanced
33 (75.0)
26 (92.9)
Primary tumor, n (%)
0.821
Gastrointestinal
8 (18.2)
7 (25.0)
Bronchus and lung
8 (18.2)
4 (14.3)
Breast
2 (4.5)
1 (3.6)
Head and neck
17 (38.6)
7 (25.0)
Hematological
1 (2.3)
0 (0)
Gynecological
4 (9.1)
5 (17.9)
Urological
3 (6.8)
3 (10.7)
Musculoskeletal
1 (2.3)
1 (3.6)
Pain medications taken, n (%)
Opioids
39 (88.6)
24 (85.7)
0.728
Acetaminophen
20 (45.5)
13 (46.4)
1.000
NSAIDs
6 (13.6)
2 (7.1)
0.471
Anticonvulsants
16 (36.4)
16 (57.1)
0.095
Antidepressants
5 (11.4)
5 (17.9)
0.496
Laxatives
18 (40.9)
9 (32.1)
0.618
Antiemetics
4 (9.1)
3 (10.7)
1.000
MEDD prescription, median (IQR)
50.0 (16.0–80.0)
68.0 (12.0–91.0)
0.768
MEDD taken, median (IQR)
20.0 (10.0–30.0)
24.5 (10.0–39.0)
0.625
History of radiation therapy before study
18 (40.9)
12 (42.9)
1.000
History of radiation during pain care
18 (40.9)
2 (7.1)
0.002
BMI: Body Mass Index; NRS: Numerical Rating Scale; NSAIDs: Nonsteroidal Anti-Inflammatory Drugs; MEDD: Morphine Equivalent Diary Dosage. indicates statistically significant difference using Mann–Whitney U test and Chi-square test.
